Abstract

Background

Few studies have compared gait speed and its correlates among different ethnogeographic regions. The goals of this study were to describe usual and rapid gait speed, and identify their correlates across Australian, Asian, and African countries.

Methods

We used data from 6 population-based cohorts of adults aged 65+ from 6 countries and 3 continents (N = 6 472), with samples ranging from 231 to 1 913. All cohorts are members of the Cohort Studies of Memory in an International Consortium collaboration. We investigated whether clinical (body mass index [BMI], hypertension, stroke, apolipoprotein status), psychological (cognition, mood, general health), and behavioral factors (smoking, drinking, physical activity) correlated with usual (N = 4 cohorts) and rapid gait speed (N = 3 cohorts) similarly across cohorts. Regression models were controlled for age, sex, and education, and were sex-stratified.

Results

Age- and sex-standardized usual gait speed means ranged from 0.61 to 1.06 m/s and rapid gait speed means ranged from 1.16 to 1.64 m/s. Lower BMI and better cognitive function consistently correlated with faster gait speed in all cohorts. Less consistently, not having hypertension and greater physical activity engagement were associated with faster gait speed. Associations with mood, smoking, and drinking were largely nonsignificant. These patterns were not attenuated by demographics. There was limited evidence that the associations differed by sex, except physical activity, where the greater intensity was associated with usual gait among men but not women.

Conclusions

This study is among the first to describe the usual and rapid gait speeds across older adults in Africa, Asia, and Australia.

Older age is marked by a wide heterogeneity in terms of disability, cognitive impairment, falls, and mortality risk (1,2). Screening tools that can be applied quickly, safely, reliably, and sensitively (but not necessarily specifically) predicting adverse health outcomes in the clinic and research settings alike are of great interest (2). Many tools have been developed with varying degrees of adoption for such settings (3). Gait speed, typically assessed as one’s preferred walking pace over a particular distance (eg, 6 m), is a mobility instrument that is a particularly useful measure of multisystemic well-being among older adults (3). Previous research has confirmed its utility as a predictor of adverse health, including future dementia, falls, and mortality risk (4). Additionally, gait speed is recognized as among the mobility tools most appropriate for clinical and research settings due to its ease of administration and predictive validity (3,5,6). Correlates of gait speed have been examined in large cohorts of healthy older adults, but epidemiologic evidence has not examined whether these correlates are similar across different ethnogeographic contexts. Such correlates could be targeted for future intervention, with the possibility that the interventions may need to be tailored to the needs of specific ethnogeographic populations.

Although a growing body of literature has established the importance of gait in older adulthood, most evidence is from samples living in Western, educated, industrialized, rich, and democratic (WEIRD) countries (7). Accordingly, there are some limitations to the generalizability of these findings to non-WEIRD samples. For example, the quantification of “slow gait” has proven difficult as there is marked heterogeneity across settings, collection methods, and testing protocols (8–10); furthermore, this work is generally based on cohort studies from high-income countries (11). Additionally, normalizing gait speed data based on 1 racial/ethnic group limits its generalizability as there are documented racial disparities in gait speed (12–14). Emerging evidence from low- and middle-income countries suggests the average gait speeds of community-dwelling older adults vary more across countries than would be expected based on the data from high-income countries. For instance, the average gait speed of community-dwelling older adults ranged from 0.61 m/s in Russia to 0.88 m/s in China (11). These estimates are similar to those previously reported among Cohort Studies of Memory in an International Consortium (COSMIC) collaboration sites such as Nigeria (15) and thus comparable to what we should expect for the current study. When using a conservative cutoff for slow gait, for example, 0.6 m/s, a sizeable proportion of older adults in these countries would, therefore, be considered as having impaired gait and being at increased risk of falls, dementia, or mortality. Although it is possible that the majority of older adults in these contexts actually experience mobility limitations that impede everyday life, it is likely that their slower gait speed performance does not necessarily reflect their performance in the context of their living environment. For example, sex- and ethnicity-based cutpoints outperformed standardized cutpoints in predicting 4-year mortality among older adults in the Health and Retirement Study cohort (16). When establishing population-specific cutoffs for slow gait, it is critical to carefully characterize gait speeds among community-dwelling older adults across different ethnogeographic contexts. By first quantifying gait speed among underrepresented regions, researchers can identify whether current and/or universal cutoffs for slow gait are reasonable across different ethnogeographic regions.

In addition to quantifying gait speed averages among community-dwelling older adults across different ethnogeographic regions, it is important to examine whether locomotor risk and protective correlates are similarly related to gait speed across regions. Many factors contribute to mobility in older adulthood, including demographic characteristics, health behaviors, genetics, and central and peripheral nervous system integrity and function (17). These factors may, however, not correlate with mobility to the same degree across different ethnogeographic contexts. For example, there is substantial variability in the prevalence and incidence of falling across countries that may be attributable to a complex interaction of intrinsic (person-specific) and external (environmental) factors (18) https://sciwheel.com/work/citation?ids=9498178&pre=&suf=&sa=0&dbf=0. Thus, it is possible that correlates of mobility in 1 sample may not replicate in a different ethnogeographic region. Insight into correlates of (slow) gait speed can better inform international policy-makers about which mobility promotion strategies may be more appropriate for worldwide use. Additionally, sample-specific correlates could be used to further tailor country-specific health priorities to promote older adult mobility. To address these limitations, the aims of the current study were to (a) describe the gait speed of community-dwelling older adults across different ethnogeographic regions and (b) identify correlates of gait speed among the different regions. Finally, we discuss which correlates are consistent across cohorts. As there were too few studies to conduct formal meta-regressions (19), this was a narrative rather than quantitative evaluation for cross-cohort comparisons.

Method

Contributing Studies and Participants

This study was conducted on cross-sectional data from 6 participating members of COSMIC, covering 6 countries from 3 continents (Table 1). Participants were excluded from analysis if they were (a) younger than 65, (b) had a self-reported diagnosis of Parkinson’s disease, (c) or were missing gait speed. Table 2 shows the demographic characteristics of the samples used in our analyses, and Supplementary Figure 1 illustrates how the analytic sample for each cohort was derived. Supplementary Table 1 provides information on the recruitment, eligibility, and abbreviated data collection protocol for each contributing study. Each of the cohorts contributing data to the present study had previously obtained ethics approval from their respective institutional review boards, and all participants within the studies provided consent. The use of these data for the present study did not warrant further participant consent as all data were de-identified prior to their release from COSMIC.

Table 1.

Contributing Studies (in alphabetical order).

StudyAbbreviationCountryGait OutcomeYear of Gait Data CollectionLength of Walkway (m)
Identification and Intervention for Dementia in Elderly Africans (20)
(N = 231)
IDEATanzaniaUsual gait speed201410 meters
Ibadan Study of Aging (21)
(N = 1 122)
ISANigeriaUsual gait speed20073 or 4
Korean Longitudinal Study on Cognitive Aging and Dementia (22)
(N = 491)
KLOSCADSouth KoreaUsual gait speed; rapid gait speed2010–201210
Sasaguri Genkimon Study (23)
(N = 1 913)
SGSJapanRapid gait speed20115
Singapore Longitudinal Study of Aging-II (24)
(N = 1 698)
SLAS-IISingaporeRapid gait speed2009–20116
Sydney Memory and Ageing Study (25)
(N = 995)
Sydney MASAustraliaUsual gait speed20056
StudyAbbreviationCountryGait OutcomeYear of Gait Data CollectionLength of Walkway (m)
Identification and Intervention for Dementia in Elderly Africans (20)
(N = 231)
IDEATanzaniaUsual gait speed201410 meters
Ibadan Study of Aging (21)
(N = 1 122)
ISANigeriaUsual gait speed20073 or 4
Korean Longitudinal Study on Cognitive Aging and Dementia (22)
(N = 491)
KLOSCADSouth KoreaUsual gait speed; rapid gait speed2010–201210
Sasaguri Genkimon Study (23)
(N = 1 913)
SGSJapanRapid gait speed20115
Singapore Longitudinal Study of Aging-II (24)
(N = 1 698)
SLAS-IISingaporeRapid gait speed2009–20116
Sydney Memory and Ageing Study (25)
(N = 995)
Sydney MASAustraliaUsual gait speed20056
Table 1.

Contributing Studies (in alphabetical order).

StudyAbbreviationCountryGait OutcomeYear of Gait Data CollectionLength of Walkway (m)
Identification and Intervention for Dementia in Elderly Africans (20)
(N = 231)
IDEATanzaniaUsual gait speed201410 meters
Ibadan Study of Aging (21)
(N = 1 122)
ISANigeriaUsual gait speed20073 or 4
Korean Longitudinal Study on Cognitive Aging and Dementia (22)
(N = 491)
KLOSCADSouth KoreaUsual gait speed; rapid gait speed2010–201210
Sasaguri Genkimon Study (23)
(N = 1 913)
SGSJapanRapid gait speed20115
Singapore Longitudinal Study of Aging-II (24)
(N = 1 698)
SLAS-IISingaporeRapid gait speed2009–20116
Sydney Memory and Ageing Study (25)
(N = 995)
Sydney MASAustraliaUsual gait speed20056
StudyAbbreviationCountryGait OutcomeYear of Gait Data CollectionLength of Walkway (m)
Identification and Intervention for Dementia in Elderly Africans (20)
(N = 231)
IDEATanzaniaUsual gait speed201410 meters
Ibadan Study of Aging (21)
(N = 1 122)
ISANigeriaUsual gait speed20073 or 4
Korean Longitudinal Study on Cognitive Aging and Dementia (22)
(N = 491)
KLOSCADSouth KoreaUsual gait speed; rapid gait speed2010–201210
Sasaguri Genkimon Study (23)
(N = 1 913)
SGSJapanRapid gait speed20115
Singapore Longitudinal Study of Aging-II (24)
(N = 1 698)
SLAS-IISingaporeRapid gait speed2009–20116
Sydney Memory and Ageing Study (25)
(N = 995)
Sydney MASAustraliaUsual gait speed20056
Table 2.

Demographic, Clinical, Psychological, and Behavioral Characteristics of the Contributing COSMIC Studies.

Tanzania (IDEA; N = 231)Nigeria (ISA; N = 1 122)South Korea (KLOSCAD; N = 491)Japan (SGS; N = 1 913)Singapore (SLAS-II; N = 1 698)Australia (Sydney MAS; N = 995)
Age (years)80.47 (8.30)76.85 (7.87)73.25 (5.27)73.59 (6.09)72.41 (5.84)78.78 (4.79)
Sex (% Women)162 (69.8%)577 (51.4%)272 (55.4%)1 112 (58.1%)1 004 (59.1%)549 (55.2%)
Education (years)
 0–6None: 130 (58.6%)893 (79.6%)60 (12.2%)40 (2.1%)1 247 (74.8%)21 (2.1%)
 7–12Did not complete primary: 81 (36.5%)153 (13.6%)177 (36.0%)1 550 (81.2%)381 (22.8%)622 (62.5%)
 13+At least primary: 11 (4.9%)76 (6.8%)255 (51.8%) 319 (16.7%)40 (2.4%)352 (35.4%)
BMI (kg/m2)NA22.38 (4.42)24.01 (2.62)23.21 (3.20)23.98 (4.02)27.09 (4.47)
Hypertension (% yes)75 (38.1%)171 (15.3%)281 (57.1%)744 (38.9%)989 (58.3%)600 (60.4%)
Stroke11 (4.8%)52 (4.7%)NA72 (3.8%)87 (5.1%)38 (3.9%)
APOE e4 status (% with at least 1 allele)NANA99 (20.2%)NA273 (18.9%)214 (22.6%)
MMSE (total score)NANA27.59 (2.29)27.45 (2.40)27.08 (3.35)28.0 (1.51)
Categorical fluency (raw score)5.28 (3.52)12.51 (4.12)18.13 (5.32)NA19.26 (4.93)15.60 (4.37)
Trail-Making Test A (total time)NANA49.38 (31.03)NA98.24 (51.00)46.71 (16.19)
Trail-Making Test B (total time)NANA149.31 (79.04)NA155.62 (57.65)119.72 (53.125)
Trail-Making Test B − A (total time)NANA101.04 (65.47)NA67.62 (43.32)73.82 (46.36)
Depressive symptoms: Geriatric Depression ScaleNANA8.26 (5.94) (30-item)NA0.83 (1.57) (30-item)2.27 (2.09) (15-item)
General health
 Poor159 (68.5%)31 (2.8%)245 (49.8%)405 (21.3%)535 (32.1%)158 (16.0%)
 Good73 (31.5%)1 079 (96.2%)247 (50.2%)1 500 (78.7%)1 131 (67.9%)834 (84.1%)
Current smoker (% yes)73 (32.4%)466 (41.8%)23 (4.7%)154 (8.1%)58 (3.7%)31 (3.1%)
Current drinker (% yes)94 (42.73%)644 (58.4%)144 (29.3%)1 285 (67.3%)36 (2.4%)870 (87.4%)
Physical activity
 Minimally active111 (49.6%)NA83 (16.9%)NA275 (16.2%)136 (14.1%)
 Moderately active97 (43.3%)250 (50.9%)1 141 (67.4%)505 (52.2%)
 Vigorously active16 (7.1%)158 (32.2%)276 (16.3%)326 (33.7%)
Raw usual gait speed (m/s)0.52 (0.24)0.77 (0.23)1.09 (0.25)NANA0.70 (0.17)
Adjusted usual gait speed (m/s)0.61 (0.21)0.78 (0.22)1.06 (0.24)NANA0.74 (0.16)
Raw rapid gait speed (m/s)NANA1.34 (0.32)1.68 (0.44)1.20 (0.34)NA
Adjusted rapid gait speed (m/s)NANA1.31 (0.30)1.65 (0.38)1.16 (0.33)NA
Tanzania (IDEA; N = 231)Nigeria (ISA; N = 1 122)South Korea (KLOSCAD; N = 491)Japan (SGS; N = 1 913)Singapore (SLAS-II; N = 1 698)Australia (Sydney MAS; N = 995)
Age (years)80.47 (8.30)76.85 (7.87)73.25 (5.27)73.59 (6.09)72.41 (5.84)78.78 (4.79)
Sex (% Women)162 (69.8%)577 (51.4%)272 (55.4%)1 112 (58.1%)1 004 (59.1%)549 (55.2%)
Education (years)
 0–6None: 130 (58.6%)893 (79.6%)60 (12.2%)40 (2.1%)1 247 (74.8%)21 (2.1%)
 7–12Did not complete primary: 81 (36.5%)153 (13.6%)177 (36.0%)1 550 (81.2%)381 (22.8%)622 (62.5%)
 13+At least primary: 11 (4.9%)76 (6.8%)255 (51.8%) 319 (16.7%)40 (2.4%)352 (35.4%)
BMI (kg/m2)NA22.38 (4.42)24.01 (2.62)23.21 (3.20)23.98 (4.02)27.09 (4.47)
Hypertension (% yes)75 (38.1%)171 (15.3%)281 (57.1%)744 (38.9%)989 (58.3%)600 (60.4%)
Stroke11 (4.8%)52 (4.7%)NA72 (3.8%)87 (5.1%)38 (3.9%)
APOE e4 status (% with at least 1 allele)NANA99 (20.2%)NA273 (18.9%)214 (22.6%)
MMSE (total score)NANA27.59 (2.29)27.45 (2.40)27.08 (3.35)28.0 (1.51)
Categorical fluency (raw score)5.28 (3.52)12.51 (4.12)18.13 (5.32)NA19.26 (4.93)15.60 (4.37)
Trail-Making Test A (total time)NANA49.38 (31.03)NA98.24 (51.00)46.71 (16.19)
Trail-Making Test B (total time)NANA149.31 (79.04)NA155.62 (57.65)119.72 (53.125)
Trail-Making Test B − A (total time)NANA101.04 (65.47)NA67.62 (43.32)73.82 (46.36)
Depressive symptoms: Geriatric Depression ScaleNANA8.26 (5.94) (30-item)NA0.83 (1.57) (30-item)2.27 (2.09) (15-item)
General health
 Poor159 (68.5%)31 (2.8%)245 (49.8%)405 (21.3%)535 (32.1%)158 (16.0%)
 Good73 (31.5%)1 079 (96.2%)247 (50.2%)1 500 (78.7%)1 131 (67.9%)834 (84.1%)
Current smoker (% yes)73 (32.4%)466 (41.8%)23 (4.7%)154 (8.1%)58 (3.7%)31 (3.1%)
Current drinker (% yes)94 (42.73%)644 (58.4%)144 (29.3%)1 285 (67.3%)36 (2.4%)870 (87.4%)
Physical activity
 Minimally active111 (49.6%)NA83 (16.9%)NA275 (16.2%)136 (14.1%)
 Moderately active97 (43.3%)250 (50.9%)1 141 (67.4%)505 (52.2%)
 Vigorously active16 (7.1%)158 (32.2%)276 (16.3%)326 (33.7%)
Raw usual gait speed (m/s)0.52 (0.24)0.77 (0.23)1.09 (0.25)NANA0.70 (0.17)
Adjusted usual gait speed (m/s)0.61 (0.21)0.78 (0.22)1.06 (0.24)NANA0.74 (0.16)
Raw rapid gait speed (m/s)NANA1.34 (0.32)1.68 (0.44)1.20 (0.34)NA
Adjusted rapid gait speed (m/s)NANA1.31 (0.30)1.65 (0.38)1.16 (0.33)NA

Notes: APOE = apolipoprotein; BMI = body mass index; COSMIC = Cohort Studies of Memory in an International Consortium; IDEA = Intervention for Dementia in Elderly Africans; ISA = Ibadan Study of Aging; KLOSCAD = Korean Longitudinal Study on Cognitive Aging and Dementia; NA = not applicable; SGS = Sasaguri Genkimon Study; SLAS-II = Singapore Longitudinal Study of Aging-II; Sydney MAS = Sydney Memory and Ageing Study.

Table 2.

Demographic, Clinical, Psychological, and Behavioral Characteristics of the Contributing COSMIC Studies.

Tanzania (IDEA; N = 231)Nigeria (ISA; N = 1 122)South Korea (KLOSCAD; N = 491)Japan (SGS; N = 1 913)Singapore (SLAS-II; N = 1 698)Australia (Sydney MAS; N = 995)
Age (years)80.47 (8.30)76.85 (7.87)73.25 (5.27)73.59 (6.09)72.41 (5.84)78.78 (4.79)
Sex (% Women)162 (69.8%)577 (51.4%)272 (55.4%)1 112 (58.1%)1 004 (59.1%)549 (55.2%)
Education (years)
 0–6None: 130 (58.6%)893 (79.6%)60 (12.2%)40 (2.1%)1 247 (74.8%)21 (2.1%)
 7–12Did not complete primary: 81 (36.5%)153 (13.6%)177 (36.0%)1 550 (81.2%)381 (22.8%)622 (62.5%)
 13+At least primary: 11 (4.9%)76 (6.8%)255 (51.8%) 319 (16.7%)40 (2.4%)352 (35.4%)
BMI (kg/m2)NA22.38 (4.42)24.01 (2.62)23.21 (3.20)23.98 (4.02)27.09 (4.47)
Hypertension (% yes)75 (38.1%)171 (15.3%)281 (57.1%)744 (38.9%)989 (58.3%)600 (60.4%)
Stroke11 (4.8%)52 (4.7%)NA72 (3.8%)87 (5.1%)38 (3.9%)
APOE e4 status (% with at least 1 allele)NANA99 (20.2%)NA273 (18.9%)214 (22.6%)
MMSE (total score)NANA27.59 (2.29)27.45 (2.40)27.08 (3.35)28.0 (1.51)
Categorical fluency (raw score)5.28 (3.52)12.51 (4.12)18.13 (5.32)NA19.26 (4.93)15.60 (4.37)
Trail-Making Test A (total time)NANA49.38 (31.03)NA98.24 (51.00)46.71 (16.19)
Trail-Making Test B (total time)NANA149.31 (79.04)NA155.62 (57.65)119.72 (53.125)
Trail-Making Test B − A (total time)NANA101.04 (65.47)NA67.62 (43.32)73.82 (46.36)
Depressive symptoms: Geriatric Depression ScaleNANA8.26 (5.94) (30-item)NA0.83 (1.57) (30-item)2.27 (2.09) (15-item)
General health
 Poor159 (68.5%)31 (2.8%)245 (49.8%)405 (21.3%)535 (32.1%)158 (16.0%)
 Good73 (31.5%)1 079 (96.2%)247 (50.2%)1 500 (78.7%)1 131 (67.9%)834 (84.1%)
Current smoker (% yes)73 (32.4%)466 (41.8%)23 (4.7%)154 (8.1%)58 (3.7%)31 (3.1%)
Current drinker (% yes)94 (42.73%)644 (58.4%)144 (29.3%)1 285 (67.3%)36 (2.4%)870 (87.4%)
Physical activity
 Minimally active111 (49.6%)NA83 (16.9%)NA275 (16.2%)136 (14.1%)
 Moderately active97 (43.3%)250 (50.9%)1 141 (67.4%)505 (52.2%)
 Vigorously active16 (7.1%)158 (32.2%)276 (16.3%)326 (33.7%)
Raw usual gait speed (m/s)0.52 (0.24)0.77 (0.23)1.09 (0.25)NANA0.70 (0.17)
Adjusted usual gait speed (m/s)0.61 (0.21)0.78 (0.22)1.06 (0.24)NANA0.74 (0.16)
Raw rapid gait speed (m/s)NANA1.34 (0.32)1.68 (0.44)1.20 (0.34)NA
Adjusted rapid gait speed (m/s)NANA1.31 (0.30)1.65 (0.38)1.16 (0.33)NA
Tanzania (IDEA; N = 231)Nigeria (ISA; N = 1 122)South Korea (KLOSCAD; N = 491)Japan (SGS; N = 1 913)Singapore (SLAS-II; N = 1 698)Australia (Sydney MAS; N = 995)
Age (years)80.47 (8.30)76.85 (7.87)73.25 (5.27)73.59 (6.09)72.41 (5.84)78.78 (4.79)
Sex (% Women)162 (69.8%)577 (51.4%)272 (55.4%)1 112 (58.1%)1 004 (59.1%)549 (55.2%)
Education (years)
 0–6None: 130 (58.6%)893 (79.6%)60 (12.2%)40 (2.1%)1 247 (74.8%)21 (2.1%)
 7–12Did not complete primary: 81 (36.5%)153 (13.6%)177 (36.0%)1 550 (81.2%)381 (22.8%)622 (62.5%)
 13+At least primary: 11 (4.9%)76 (6.8%)255 (51.8%) 319 (16.7%)40 (2.4%)352 (35.4%)
BMI (kg/m2)NA22.38 (4.42)24.01 (2.62)23.21 (3.20)23.98 (4.02)27.09 (4.47)
Hypertension (% yes)75 (38.1%)171 (15.3%)281 (57.1%)744 (38.9%)989 (58.3%)600 (60.4%)
Stroke11 (4.8%)52 (4.7%)NA72 (3.8%)87 (5.1%)38 (3.9%)
APOE e4 status (% with at least 1 allele)NANA99 (20.2%)NA273 (18.9%)214 (22.6%)
MMSE (total score)NANA27.59 (2.29)27.45 (2.40)27.08 (3.35)28.0 (1.51)
Categorical fluency (raw score)5.28 (3.52)12.51 (4.12)18.13 (5.32)NA19.26 (4.93)15.60 (4.37)
Trail-Making Test A (total time)NANA49.38 (31.03)NA98.24 (51.00)46.71 (16.19)
Trail-Making Test B (total time)NANA149.31 (79.04)NA155.62 (57.65)119.72 (53.125)
Trail-Making Test B − A (total time)NANA101.04 (65.47)NA67.62 (43.32)73.82 (46.36)
Depressive symptoms: Geriatric Depression ScaleNANA8.26 (5.94) (30-item)NA0.83 (1.57) (30-item)2.27 (2.09) (15-item)
General health
 Poor159 (68.5%)31 (2.8%)245 (49.8%)405 (21.3%)535 (32.1%)158 (16.0%)
 Good73 (31.5%)1 079 (96.2%)247 (50.2%)1 500 (78.7%)1 131 (67.9%)834 (84.1%)
Current smoker (% yes)73 (32.4%)466 (41.8%)23 (4.7%)154 (8.1%)58 (3.7%)31 (3.1%)
Current drinker (% yes)94 (42.73%)644 (58.4%)144 (29.3%)1 285 (67.3%)36 (2.4%)870 (87.4%)
Physical activity
 Minimally active111 (49.6%)NA83 (16.9%)NA275 (16.2%)136 (14.1%)
 Moderately active97 (43.3%)250 (50.9%)1 141 (67.4%)505 (52.2%)
 Vigorously active16 (7.1%)158 (32.2%)276 (16.3%)326 (33.7%)
Raw usual gait speed (m/s)0.52 (0.24)0.77 (0.23)1.09 (0.25)NANA0.70 (0.17)
Adjusted usual gait speed (m/s)0.61 (0.21)0.78 (0.22)1.06 (0.24)NANA0.74 (0.16)
Raw rapid gait speed (m/s)NANA1.34 (0.32)1.68 (0.44)1.20 (0.34)NA
Adjusted rapid gait speed (m/s)NANA1.31 (0.30)1.65 (0.38)1.16 (0.33)NA

Notes: APOE = apolipoprotein; BMI = body mass index; COSMIC = Cohort Studies of Memory in an International Consortium; IDEA = Intervention for Dementia in Elderly Africans; ISA = Ibadan Study of Aging; KLOSCAD = Korean Longitudinal Study on Cognitive Aging and Dementia; NA = not applicable; SGS = Sasaguri Genkimon Study; SLAS-II = Singapore Longitudinal Study of Aging-II; Sydney MAS = Sydney Memory and Ageing Study.

Measures and Harmonization

Of the 6 contributing studies, 4 provided usual and 3 provided rapid gait speed (Korean Longitudinal Study on Cognitive Aging and Dementia [KLOSCAD] provided both). Table 1 shows these details, as well as the year of data collection.

Gait speed was presented in meters per second. Walkway lengths ranged from 3 to 10 m (Table 1). If necessary, the total time to complete the walkway was converted to gait speed in meters per second. In the usual gait conditions, participants were instructed to walk at their normal speed across a path. In the rapid gait conditions, participants were instructed to walk as quickly as possible. Age- and sex-normalized gait speeds were also calculated to reflect what the gait speed would be if the cohort had an average age of 75 and 50% women.

Demographic information included age, sex, and education. There was substantial overlap between the cohorts with regard to age; participants between the ages of 70 and 90 were well represented in these samples, and there were a number of young–old adults between 65 and 69 as well. Cohorts reporting centenarians or older tended to be from Africa and may reflect their more expansive inclusion criteria allowing for home-based assessments or age estimation error due to the lack of formal birth documentation for age verification. Education data for most studies were harmonized by forming a 3-category variable: (0) less than 7 years of education; (1) between 7 and 12 years of education; or (3) 13+ years. No participants from the Identification and Intervention for Dementia in Elderly Africans (IDEA) sample reported education greater than primary school, and we divided their data into tertiles reflecting (0) no formal education, (1) did not complete primary school, or (2) completed primary school. All contributing studies provided detail on these covariates. Details on how education data were harmonized are provided in Supplementary Table 2.

Data for several clinical correlates of gait speed included body mass index (BMI; calculated from height and weight if BMI was not provided in data set), as well as hypertension and stroke (both self-reported). Data for these covariates were available in all cohorts except BMI (not assessed in Tanzania) and stroke (not assessed in South Korea). Information on how these variables were harmonized across studies is provided in Supplementary Tables 3–5. We also included the apolipoprotein (APOE) ε4 polymorphism, which has been previously associated with poor performance-based mobility (26). Participants were coded as either having no (0) or at least 1 ε4 allele (1). APOE data were obtained in the South Korean, Singaporean, and Australian studies; cohort-specific details of the APOE protocol can be found in Supplementary Table 6.

Psychological correlates of gait speed included measures of cognition, mood, and subjective health. Cognitive tests included the Mini-Mental State Examination (MMSE) (27), categorical fluency (28), and Trail-Making Tasks A and B (TMT) (29). For the MMSE and categorical fluency tests, higher scores reflect better test performance. Conversely, higher TMT values reflect a slower time to complete (ie, worse performance). We reported TMT-B results in both their raw form as well as adjusted for TMT-A performance (TMT-B speed minus TMT-A speed). MMSE was assessed in all cohorts except Tanzania and Nigeria. Categorical fluency was assessed in all cohorts, except Japan. The TMT-A and TMT-B were assessed only in the South Korean, Singaporean, and Australian cohorts. Details on the cognitive assessment protocol can be found in Supplementary Table 7. Depressive symptoms were assessed using either the 15- or 30-item Geriatric Depression Scale (GDS); higher scores reflected greater depressive symptomatology (30). Depressive symptoms using either version of the GDS were assessed in the South Korean, Singaporean, and Australian cohorts; further information can be found in Supplementary Table 8. General health was assessed using a single-item question about one’s perceptions of their general health; this measure reflects both self-perceptions of mental and physical health (31) and thus was considered a psychological correlate in this study. Because all studies did not include the same set of response options, scores were converted into a binary variable. Those who reported “excellent,” “very good,” or “good” health were coded as having “good” health, and those reporting either “fair” or “poor” health were coded as having “poor” health. General health was assessed in all cohorts. Information on data harmonization for general health can be found in Supplementary Table 9.

Finally, multiple behavioral correlates of gait speed were considered. Self-reported current smoking and drinking were coded as current use (1), regardless of quantity, or abstention (0). Data for these behaviors were available for all cohorts. Information on data harmonization for smoking and drinking can be found in Supplementary Tables 10 and 11. Self-reported physical activity participation was harmonized across studies into tertiles. Participants reporting no engagement in physical activities of any intensity were “minimally active”; those who reported engaging in moderate activity at least once a week were coded as “moderately active”; those reporting frequent (>1 time/wk) engagement in active sports (eg, swimming) were reported as “vigorously active.” Additional detail for how physical activity data were harmonized can be found in Supplementary Table 12. Self-reported physical activity data were available in the South Korean, Singaporean, and Australian cohorts.

Statistical Analysis

For all analyses, cohorts were analyzed separately. Bivariate associations between gait speed and demographic, health, and cognitive variables were calculated using Spearman’s rho, independent samples’ t tests, or chi-square tests as appropriate. We then examined the associations between health, cognition, and gait speed after controlling for demographic characteristics in a series of multiple regressions. The general form for these equations were as follows:

Data were analyzed using SAS, version 9.4 (SAS Institute, Cary, NC). The significance for all tests was set at p < .05.

Results

Sample Description

Sample sizes across cohorts ranged from 231 (IDEA) to 1 913 (Sasaguri Genkimon Study [SGS]). Participant characteristics are reported in Table 2. The cohorts had an average age between 73.2 (South Korea) and 80.5 (Tanzania) years old. In all cohorts, more than 50% of the analytic sample were women.

Usual Gait Speed

Across the 4 studies with data, the average (raw) usual gait speed ranged from 0.52 (Tanzania) to 1.09 (South Korea) m/s, and age-/gender-normalized usual gait speed ranged from 0.61 (Tanzania) to 1.06 (South Korea) m/s. Demographic, clinical, and cognitive factors were generally associated with usual gait speed, and this pattern was largely consistent across data sets. In unadjusted analyses, age, depressive symptoms, BMI, and cognition showed the largest standardized association with usual gait speed (in the small-to-medium range in terms of relationship magnitude), whereas current smoking and having an APOE ε4 allele showed no association (small relationship magnitude range; Supplementary Figures 2–4 and Supplementary Table 12).

Controlling for demographics somewhat attenuated the associations with usual gait speed. As shown in Table 3, having a lower BMI, better cognitive function, and reporting at least moderate physical activity were significantly associated with faster usual gait speed after adjusting for demographics. The significant associations were small (ie, standardized β < 0.30) but consistent across studies. For example, the demographic-adjusted association between categorical fluency and usual gait speed ranged from β = 0.10–0.16 across the 3 studies with data. Finally, demographics-adjusted current health conditions, smoking status, alcohol use, and APOE ε4 status were not significantly associated with usual gait speed across studies. These relationships were not only statistically nonsignificant, but their standardized magnitudes were also small. Results were largely consistent in sex-stratified analyses between men and women and across cohorts (Table 3). One notable exception was in physical activity, whereby men reporting vigorous physical activity were significantly faster than minimally active men. Among women, however, this association was less consistent across cohorts.

Table 3.

Correlates of Usual Gait Speed Adjusted for Demographics

Tanzania (N = 231)Nigeria (N = 1 122)South Korea (N = 491)Australia (N = 995)
Unstandardized B (SE), p ValueβUnstandardized B (SE), p ValueβUnstandardized B (SE), p ValueβUnstandardized B (SE), p Valueβ
BMI−0.003 (0.001), p = .05−0.06−0.02 (.004), p <.001♂,♀−.18−0.007 (0.001), p < .001♂,♀−0.19
Hypertension−0.04 (0.03), p = .22−0.08−0.04 (0.02), p = .04−0.06−0.04 (0.02), p = .04−.06−0.03 (0.01), p = .001♀−0.10
Stroke−0.12 (0.07), p = .07♀−0.110.04 (0.03), p = .19♂0.04−0.09 (0.03), p < .001
♂,♀
−0.11
≥1 APOE ε4 allele−0.01 (0.03), p = .63−0.02−0.01 (0.01), p = .29−0.03
MMSE0.01 (0.005), p = .02♀0.110.008 (0.003), p = .02♂,♀0.07
Categorical Fluency(0.004), p = .01♂0.150.01 (0.002), p < .001♂,♀0.160.005 (0.0002), p = .040.100.005 (0.001), p <.001♂,♀0.13
Trail-Making Task A−0.001 (<0.001), p = .04−0.10−0.002 (<0.001), p < .001♂,♀−0.22
Trail-Making Task B−0.004 (<0.001), p = .01−0.13−0.005 (<0.001), p < .001♂,♀−0.17
Trail-Making Task B − A−0.0003 (<0.001), p = .06−0.09−0.0004 (<0.001), p < .001♀−0.12
Depressive symptoms−0.003 (0.002), p = .08−0.07−0.01 (0.002), p < .001♀−0.13
General health = Good0.02 (0.03), p = .430.110.14 (0.04), p < .001♀0.110.04 (0.02), p = .050.090.06 (0.01), p < .001♀0.12
Current smoker0.02 (0.04), p = .550.050.003 (0.01), p = .86.006−0.01 (0.05), p = .77−0.010.002 (0.03), p = .950.002
Current drinker0.06 (0.03), p = .06♀0.12−0.003 (0.01), p = .98−.0010.04 (0.03), p = .120.080.03 (0.01), p = .060.06
Moderate physical activity (vs minimal)0.10 (0.03), p < .001♂,♀0.220.06 (0.03), p = .04♂0.120.05 (0.02), p = .001♀0.10
Vigorous physical activity (vs minimal).01 (0.04), p = .01♂0.240.05 (0.03), p = .12♂0.100.07 (0.02), p < .001♂,♀0.13
Tanzania (N = 231)Nigeria (N = 1 122)South Korea (N = 491)Australia (N = 995)
Unstandardized B (SE), p ValueβUnstandardized B (SE), p ValueβUnstandardized B (SE), p ValueβUnstandardized B (SE), p Valueβ
BMI−0.003 (0.001), p = .05−0.06−0.02 (.004), p <.001♂,♀−.18−0.007 (0.001), p < .001♂,♀−0.19
Hypertension−0.04 (0.03), p = .22−0.08−0.04 (0.02), p = .04−0.06−0.04 (0.02), p = .04−.06−0.03 (0.01), p = .001♀−0.10
Stroke−0.12 (0.07), p = .07♀−0.110.04 (0.03), p = .19♂0.04−0.09 (0.03), p < .001
♂,♀
−0.11
≥1 APOE ε4 allele−0.01 (0.03), p = .63−0.02−0.01 (0.01), p = .29−0.03
MMSE0.01 (0.005), p = .02♀0.110.008 (0.003), p = .02♂,♀0.07
Categorical Fluency(0.004), p = .01♂0.150.01 (0.002), p < .001♂,♀0.160.005 (0.0002), p = .040.100.005 (0.001), p <.001♂,♀0.13
Trail-Making Task A−0.001 (<0.001), p = .04−0.10−0.002 (<0.001), p < .001♂,♀−0.22
Trail-Making Task B−0.004 (<0.001), p = .01−0.13−0.005 (<0.001), p < .001♂,♀−0.17
Trail-Making Task B − A−0.0003 (<0.001), p = .06−0.09−0.0004 (<0.001), p < .001♀−0.12
Depressive symptoms−0.003 (0.002), p = .08−0.07−0.01 (0.002), p < .001♀−0.13
General health = Good0.02 (0.03), p = .430.110.14 (0.04), p < .001♀0.110.04 (0.02), p = .050.090.06 (0.01), p < .001♀0.12
Current smoker0.02 (0.04), p = .550.050.003 (0.01), p = .86.006−0.01 (0.05), p = .77−0.010.002 (0.03), p = .950.002
Current drinker0.06 (0.03), p = .06♀0.12−0.003 (0.01), p = .98−.0010.04 (0.03), p = .120.080.03 (0.01), p = .060.06
Moderate physical activity (vs minimal)0.10 (0.03), p < .001♂,♀0.220.06 (0.03), p = .04♂0.120.05 (0.02), p = .001♀0.10
Vigorous physical activity (vs minimal).01 (0.04), p = .01♂0.240.05 (0.03), p = .12♂0.100.07 (0.02), p < .001♂,♀0.13

Notes: Rows represent separate regression analyses adjusting for the sample-specific demographics (age, sex, and education). For sex-stratified results, ♂ indicates instances where the predictor was significant among men; ♀ indicates instances where the predictor was significant among women (p < .05). No symbols indicate that the variable was not significant in either sex-stratified analysis. Shaded areas denote when a variable was not available for this cohort. β reflects the standardized beta coefficient. APOE = apolipoprotein; BMI = body mass index; MMSE = Mini-Mental State Examination; SE = standard error.

Table 3.

Correlates of Usual Gait Speed Adjusted for Demographics

Tanzania (N = 231)Nigeria (N = 1 122)South Korea (N = 491)Australia (N = 995)
Unstandardized B (SE), p ValueβUnstandardized B (SE), p ValueβUnstandardized B (SE), p ValueβUnstandardized B (SE), p Valueβ
BMI−0.003 (0.001), p = .05−0.06−0.02 (.004), p <.001♂,♀−.18−0.007 (0.001), p < .001♂,♀−0.19
Hypertension−0.04 (0.03), p = .22−0.08−0.04 (0.02), p = .04−0.06−0.04 (0.02), p = .04−.06−0.03 (0.01), p = .001♀−0.10
Stroke−0.12 (0.07), p = .07♀−0.110.04 (0.03), p = .19♂0.04−0.09 (0.03), p < .001
♂,♀
−0.11
≥1 APOE ε4 allele−0.01 (0.03), p = .63−0.02−0.01 (0.01), p = .29−0.03
MMSE0.01 (0.005), p = .02♀0.110.008 (0.003), p = .02♂,♀0.07
Categorical Fluency(0.004), p = .01♂0.150.01 (0.002), p < .001♂,♀0.160.005 (0.0002), p = .040.100.005 (0.001), p <.001♂,♀0.13
Trail-Making Task A−0.001 (<0.001), p = .04−0.10−0.002 (<0.001), p < .001♂,♀−0.22
Trail-Making Task B−0.004 (<0.001), p = .01−0.13−0.005 (<0.001), p < .001♂,♀−0.17
Trail-Making Task B − A−0.0003 (<0.001), p = .06−0.09−0.0004 (<0.001), p < .001♀−0.12
Depressive symptoms−0.003 (0.002), p = .08−0.07−0.01 (0.002), p < .001♀−0.13
General health = Good0.02 (0.03), p = .430.110.14 (0.04), p < .001♀0.110.04 (0.02), p = .050.090.06 (0.01), p < .001♀0.12
Current smoker0.02 (0.04), p = .550.050.003 (0.01), p = .86.006−0.01 (0.05), p = .77−0.010.002 (0.03), p = .950.002
Current drinker0.06 (0.03), p = .06♀0.12−0.003 (0.01), p = .98−.0010.04 (0.03), p = .120.080.03 (0.01), p = .060.06
Moderate physical activity (vs minimal)0.10 (0.03), p < .001♂,♀0.220.06 (0.03), p = .04♂0.120.05 (0.02), p = .001♀0.10
Vigorous physical activity (vs minimal).01 (0.04), p = .01♂0.240.05 (0.03), p = .12♂0.100.07 (0.02), p < .001♂,♀0.13
Tanzania (N = 231)Nigeria (N = 1 122)South Korea (N = 491)Australia (N = 995)
Unstandardized B (SE), p ValueβUnstandardized B (SE), p ValueβUnstandardized B (SE), p ValueβUnstandardized B (SE), p Valueβ
BMI−0.003 (0.001), p = .05−0.06−0.02 (.004), p <.001♂,♀−.18−0.007 (0.001), p < .001♂,♀−0.19
Hypertension−0.04 (0.03), p = .22−0.08−0.04 (0.02), p = .04−0.06−0.04 (0.02), p = .04−.06−0.03 (0.01), p = .001♀−0.10
Stroke−0.12 (0.07), p = .07♀−0.110.04 (0.03), p = .19♂0.04−0.09 (0.03), p < .001
♂,♀
−0.11
≥1 APOE ε4 allele−0.01 (0.03), p = .63−0.02−0.01 (0.01), p = .29−0.03
MMSE0.01 (0.005), p = .02♀0.110.008 (0.003), p = .02♂,♀0.07
Categorical Fluency(0.004), p = .01♂0.150.01 (0.002), p < .001♂,♀0.160.005 (0.0002), p = .040.100.005 (0.001), p <.001♂,♀0.13
Trail-Making Task A−0.001 (<0.001), p = .04−0.10−0.002 (<0.001), p < .001♂,♀−0.22
Trail-Making Task B−0.004 (<0.001), p = .01−0.13−0.005 (<0.001), p < .001♂,♀−0.17
Trail-Making Task B − A−0.0003 (<0.001), p = .06−0.09−0.0004 (<0.001), p < .001♀−0.12
Depressive symptoms−0.003 (0.002), p = .08−0.07−0.01 (0.002), p < .001♀−0.13
General health = Good0.02 (0.03), p = .430.110.14 (0.04), p < .001♀0.110.04 (0.02), p = .050.090.06 (0.01), p < .001♀0.12
Current smoker0.02 (0.04), p = .550.050.003 (0.01), p = .86.006−0.01 (0.05), p = .77−0.010.002 (0.03), p = .950.002
Current drinker0.06 (0.03), p = .06♀0.12−0.003 (0.01), p = .98−.0010.04 (0.03), p = .120.080.03 (0.01), p = .060.06
Moderate physical activity (vs minimal)0.10 (0.03), p < .001♂,♀0.220.06 (0.03), p = .04♂0.120.05 (0.02), p = .001♀0.10
Vigorous physical activity (vs minimal).01 (0.04), p = .01♂0.240.05 (0.03), p = .12♂0.100.07 (0.02), p < .001♂,♀0.13

Notes: Rows represent separate regression analyses adjusting for the sample-specific demographics (age, sex, and education). For sex-stratified results, ♂ indicates instances where the predictor was significant among men; ♀ indicates instances where the predictor was significant among women (p < .05). No symbols indicate that the variable was not significant in either sex-stratified analysis. Shaded areas denote when a variable was not available for this cohort. β reflects the standardized beta coefficient. APOE = apolipoprotein; BMI = body mass index; MMSE = Mini-Mental State Examination; SE = standard error.

Rapid Gait Speed

Across the 3 studies with data, the average (raw) rapid gait speed ranged from 1.20 (Singapore) to 1.68 (Japan) m/s, and age-/gender-normalized rapid gait speed ranged from 1.16 (Singapore) to 1.65 (Japan) m/s. Unadjusted analyses found that demographic, clinical, and psychological factors were generally associated with rapid gait speed, and this pattern was largely consistent across data sets. Age, depressive symptoms, and cognition tended to have the largest standardized association with rapid gait speed (Supplementary Figures 2–4 and Supplementary Table 14). Similar to that of usual gait speed, the magnitude of these associations was in the small-to-medium range. The presence of at least 1 APOE ε4 allele was not associated with rapid gait speed in any cohort (p > .05), and the magnitude of the association was small.

Controlling for demographics somewhat attenuated the associations with rapid gait speed. Lower BMI, better cognitive function, and having at least “good” health were significantly associated with a faster usual gait speed after adjusting for demographics (Table 4). As seen for usual gait speed, associations were statistically significant, yet small (ie, standardized β < 0.30) but consistent across studies. For example, the demographic-adjusted association between general health and rapid gait speed ranged from β = 0.08–0.14 across 3 studies (see Table 4). Finally, demographics-adjusted presence of hypertension, the presence of at least 1 APOE ε4 allele, current alcohol use, and engagement in moderate (but not vigorous) physical activity were not associated with rapid gait speed in any cohort (p > .05). Not only were these relationships statistically nonsignificant, but the standardized magnitude of the relationships was small as well. Results were largely consistent in sex-stratified analyses (Table 4).

Table 4.

Correlates of Rapid Gait Speed Adjusted for Demographics

South Korea (N = 242)Japan (N = 1 913)Singapore (N = 1 698)
Unstandardized B (SE), p ValueβUnstandardized B (SE), p ValueβUnstandardized B (SE), p Valueβ
BMI−0.02 (0.005), p = .001♂, ♀−0.14−0.03 (0.01), p < .001♂−0.08−0.05 (0.01), p < .001♂, ♀−0.14
Hypertension−0.05 (0.03), p = .05−0.08−0.02 (0.02), p = .24−0.02−.055 (0.02), p = .001♀−0.08
Stroke−0.26 (0.05), p < .001♂, ♀−0.11−0.22 (0.02), p < .001♂, ♀−0.13
≥1 APOE ε4 allele−0.01 (0.03), p = .65−0.02−0.02 (0.02), p = .33−0.02
MMSE0.04 (0.13), p = .01♀0.130.03 (0.004), p < .001♂, ♀0.160.02 (0.003), p < .001♂, ♀0.19
Categorical Fluency0.006 (.003), p = .02♂0.100.01 (0.003), p < .001♂, ♀0.16
Trail-Making Task A−0.04 (0.01), p = .01♀−0.12−0.001 (<0.01), p < .001♂−0.15
Trail-Making Task B−0.05 (0.02), p = .001♂, ♀−0.16−0.001 (<0.01), p < .001♂−0.20
Trail-Making Task B − A−0.0006 (0.0002), p = .01−0.12−0.001 (<0.01), p = .01♂−0.11
Depressive symptoms−0.02 (0.01), p = .19−0.05−0.03 (0.01), p < .001♂−0.09
General health = Good0.07 (0.03), p = .01♀0.110.18 (0.02), p < .001♂, ♀0.170.06 (0.02), p = .001♂, ♀0.08
Current smoker−0.01 (0.06), p = .81−0.01−0.05 (0.03), p = .11♀−0.03−0.02 (0.04), p = .57−0.01
Current drinker0.07 (0.04), p = .070.100.02 (0.02), p = .290.020.12 (0.06), p = .03♀0.05
Moderate physical activity (vs minimal)0.06 (0.04), p = .110.090.02 (0.03), p = .370.03
Vigorous physical activity (vs minimal)0.06 (0.04), p = .150.090.12 (0.03), p < .001♂, ♀0.13
South Korea (N = 242)Japan (N = 1 913)Singapore (N = 1 698)
Unstandardized B (SE), p ValueβUnstandardized B (SE), p ValueβUnstandardized B (SE), p Valueβ
BMI−0.02 (0.005), p = .001♂, ♀−0.14−0.03 (0.01), p < .001♂−0.08−0.05 (0.01), p < .001♂, ♀−0.14
Hypertension−0.05 (0.03), p = .05−0.08−0.02 (0.02), p = .24−0.02−.055 (0.02), p = .001♀−0.08
Stroke−0.26 (0.05), p < .001♂, ♀−0.11−0.22 (0.02), p < .001♂, ♀−0.13
≥1 APOE ε4 allele−0.01 (0.03), p = .65−0.02−0.02 (0.02), p = .33−0.02
MMSE0.04 (0.13), p = .01♀0.130.03 (0.004), p < .001♂, ♀0.160.02 (0.003), p < .001♂, ♀0.19
Categorical Fluency0.006 (.003), p = .02♂0.100.01 (0.003), p < .001♂, ♀0.16
Trail-Making Task A−0.04 (0.01), p = .01♀−0.12−0.001 (<0.01), p < .001♂−0.15
Trail-Making Task B−0.05 (0.02), p = .001♂, ♀−0.16−0.001 (<0.01), p < .001♂−0.20
Trail-Making Task B − A−0.0006 (0.0002), p = .01−0.12−0.001 (<0.01), p = .01♂−0.11
Depressive symptoms−0.02 (0.01), p = .19−0.05−0.03 (0.01), p < .001♂−0.09
General health = Good0.07 (0.03), p = .01♀0.110.18 (0.02), p < .001♂, ♀0.170.06 (0.02), p = .001♂, ♀0.08
Current smoker−0.01 (0.06), p = .81−0.01−0.05 (0.03), p = .11♀−0.03−0.02 (0.04), p = .57−0.01
Current drinker0.07 (0.04), p = .070.100.02 (0.02), p = .290.020.12 (0.06), p = .03♀0.05
Moderate physical activity (vs minimal)0.06 (0.04), p = .110.090.02 (0.03), p = .370.03
Vigorous physical activity (vs minimal)0.06 (0.04), p = .150.090.12 (0.03), p < .001♂, ♀0.13

Notes: Rows represent separate regression analyses adjusting for the sample-specific demographics (age, sex, and education). For sex-stratified results, ♂ indicates instances where the predictor was significant among men; ♀ indicates instances where the predictor was significant among women (p < .05). No symbols indicate that the variable was not significant in either sex-stratified analysis. Shaded areas denote when a variable was not available for this cohort. β reflects the standardized beta coefficient. APOE = apolipoprotein; MMSE = Mini-Mental State Examination; SE = standard error.

Table 4.

Correlates of Rapid Gait Speed Adjusted for Demographics

South Korea (N = 242)Japan (N = 1 913)Singapore (N = 1 698)
Unstandardized B (SE), p ValueβUnstandardized B (SE), p ValueβUnstandardized B (SE), p Valueβ
BMI−0.02 (0.005), p = .001♂, ♀−0.14−0.03 (0.01), p < .001♂−0.08−0.05 (0.01), p < .001♂, ♀−0.14
Hypertension−0.05 (0.03), p = .05−0.08−0.02 (0.02), p = .24−0.02−.055 (0.02), p = .001♀−0.08
Stroke−0.26 (0.05), p < .001♂, ♀−0.11−0.22 (0.02), p < .001♂, ♀−0.13
≥1 APOE ε4 allele−0.01 (0.03), p = .65−0.02−0.02 (0.02), p = .33−0.02
MMSE0.04 (0.13), p = .01♀0.130.03 (0.004), p < .001♂, ♀0.160.02 (0.003), p < .001♂, ♀0.19
Categorical Fluency0.006 (.003), p = .02♂0.100.01 (0.003), p < .001♂, ♀0.16
Trail-Making Task A−0.04 (0.01), p = .01♀−0.12−0.001 (<0.01), p < .001♂−0.15
Trail-Making Task B−0.05 (0.02), p = .001♂, ♀−0.16−0.001 (<0.01), p < .001♂−0.20
Trail-Making Task B − A−0.0006 (0.0002), p = .01−0.12−0.001 (<0.01), p = .01♂−0.11
Depressive symptoms−0.02 (0.01), p = .19−0.05−0.03 (0.01), p < .001♂−0.09
General health = Good0.07 (0.03), p = .01♀0.110.18 (0.02), p < .001♂, ♀0.170.06 (0.02), p = .001♂, ♀0.08
Current smoker−0.01 (0.06), p = .81−0.01−0.05 (0.03), p = .11♀−0.03−0.02 (0.04), p = .57−0.01
Current drinker0.07 (0.04), p = .070.100.02 (0.02), p = .290.020.12 (0.06), p = .03♀0.05
Moderate physical activity (vs minimal)0.06 (0.04), p = .110.090.02 (0.03), p = .370.03
Vigorous physical activity (vs minimal)0.06 (0.04), p = .150.090.12 (0.03), p < .001♂, ♀0.13
South Korea (N = 242)Japan (N = 1 913)Singapore (N = 1 698)
Unstandardized B (SE), p ValueβUnstandardized B (SE), p ValueβUnstandardized B (SE), p Valueβ
BMI−0.02 (0.005), p = .001♂, ♀−0.14−0.03 (0.01), p < .001♂−0.08−0.05 (0.01), p < .001♂, ♀−0.14
Hypertension−0.05 (0.03), p = .05−0.08−0.02 (0.02), p = .24−0.02−.055 (0.02), p = .001♀−0.08
Stroke−0.26 (0.05), p < .001♂, ♀−0.11−0.22 (0.02), p < .001♂, ♀−0.13
≥1 APOE ε4 allele−0.01 (0.03), p = .65−0.02−0.02 (0.02), p = .33−0.02
MMSE0.04 (0.13), p = .01♀0.130.03 (0.004), p < .001♂, ♀0.160.02 (0.003), p < .001♂, ♀0.19
Categorical Fluency0.006 (.003), p = .02♂0.100.01 (0.003), p < .001♂, ♀0.16
Trail-Making Task A−0.04 (0.01), p = .01♀−0.12−0.001 (<0.01), p < .001♂−0.15
Trail-Making Task B−0.05 (0.02), p = .001♂, ♀−0.16−0.001 (<0.01), p < .001♂−0.20
Trail-Making Task B − A−0.0006 (0.0002), p = .01−0.12−0.001 (<0.01), p = .01♂−0.11
Depressive symptoms−0.02 (0.01), p = .19−0.05−0.03 (0.01), p < .001♂−0.09
General health = Good0.07 (0.03), p = .01♀0.110.18 (0.02), p < .001♂, ♀0.170.06 (0.02), p = .001♂, ♀0.08
Current smoker−0.01 (0.06), p = .81−0.01−0.05 (0.03), p = .11♀−0.03−0.02 (0.04), p = .57−0.01
Current drinker0.07 (0.04), p = .070.100.02 (0.02), p = .290.020.12 (0.06), p = .03♀0.05
Moderate physical activity (vs minimal)0.06 (0.04), p = .110.090.02 (0.03), p = .370.03
Vigorous physical activity (vs minimal)0.06 (0.04), p = .150.090.12 (0.03), p < .001♂, ♀0.13

Notes: Rows represent separate regression analyses adjusting for the sample-specific demographics (age, sex, and education). For sex-stratified results, ♂ indicates instances where the predictor was significant among men; ♀ indicates instances where the predictor was significant among women (p < .05). No symbols indicate that the variable was not significant in either sex-stratified analysis. Shaded areas denote when a variable was not available for this cohort. β reflects the standardized beta coefficient. APOE = apolipoprotein; MMSE = Mini-Mental State Examination; SE = standard error.

Discussion

In this study of gait speed among older adults from Asia, Africa, and Australia, we found that age- and gender-standardized usual gait speed ranged from 0.60 to 1.06 m/s, and rapid gait speed ranged from 1.16 to 1.65 m/s. Furthermore, BMI, cognition, and physical activity factors were the most robust correlates of gait speed across cohorts; other locomotor risk factors were either not associated with gait speed or associations were less consistent across cohorts. Although the strength of association was small, these patterns of association were not attenuated by cohort-specific demographic characteristics.

Compared to U.S.-based cohort studies of older adults living in the community, the average age-/gender-standardized gait speeds of the cohorts in the present study were substantially slower. The average usual gait speed in all cohorts except South Korea, for example, was well below the 0.95–1.2 m/s speed previously cited as “average” gait speed among community-dwelling older adults seen elsewhere (32,33); the average gait speed among our cohorts would be classified as having limited community ambulation (34). Although gait speed statistics from samples outside the United States, Europe, and Australia are less common, the range of gait speed values reflected across the COSMIC cohorts is similar to community-dwelling older adults in countries underrepresented in mobility research such as South Africa, Brazil, India, Russia, and Ghana (11,35,36). Despite the slow gait speed, these cohorts largely reported at least “good’ general health and were able to undergo the walking protocol, suggesting that these samples reflect ambulatory, community-dwelling older adults. These descriptive findings highlight the importance of ensuring the appropriateness of cutpoints developed on selected samples in high-income and western countries to other geographic cohorts. Environmental factors can affect one’s gait, including cross-country differences in height (37,38), cultural differences in healthful activity engagement (eg, physical activity) (39), and the environmental context (eg, rural vs urban-based cohort) (40). For example, Tanzanian older adults were assessed in their homes in the rural Hai District. Although efforts were made to ensure a flat walkway, the Hai District is situated at the foothills of Mount Kilimanjaro; such elevation changes may have contributed to this cohort’s slower gait speed compared to the other sites. Additionally, participants in this cohort tended to perform the gait speed task with open-toed shoes, possibly contributing to their gait speed differences. As such, it is critical that future research reflects ethnogeographically diverse regions to examine whether the factors that are associated with gait are context-specific or reflect similar associations across various populations.

These results support previous literature that clinical, psychological, and health behavior measures such as BMI, cognitive performance, depressive symptoms, and physical activity are related to older adult mobility (41). The magnitude of the effect was largely consistent across different ethnogeographic regions as well as in gender-stratified analyses. This suggests that although there is marked variability in gait speed across different regions, the associations between psychological and clinical factors with gait were remarkably consistent. Behavioral interventions to improve gait speed should be developed to address the unique experiences and contexts of the population, but the same types of interventions may confer similar benefits regardless of region of origin. For example, physical activity levels varied across samples, but the strength of the association was significant and similar across cohorts. Notably, physical activity tended to be associated with usual gait speed among women but not men. In comparison, there was some evidence to suggest that physical activity—especially at greater —may be a stronger correlate of usual gait speed among men. Sex differences in gait speed are well documented, and recent work suggests that sex moderates the gait/health outcomes association (42). Taken together, this suggests that men and women may have differential susceptibility to modifiable determinants of gait, particularly regarding physical activity. Future observational studies and intervention programs that target physical health should account for gender and sex differences in the determinants of physical aging and gait itself. There is less evidence, however, that sex-stratified behavioral interventions outside of physical activity will provide additional benefits. These results are consistent with non-U.S. population-based studies that found psychological, physical, and cognitive health are associated with older adult mobility (36). As these are cross-sectional relationships, however, we cannot ascertain the directionality of these associations.

Negative findings are also of interest. There was limited evidence that health conditions were associated with gait speed. Slower gait speed is often seen in the presence of chronic health conditions (43,44), including stroke (45) and hypertension— both untreated and treated alike (46,47). Chronic health conditions and slower gait speed are hypothesized to be linked through pathways such as systemic inflammation, physical inactivity, and depleted nutrition (48,49). Although we were able to account for some of these hypothesized mechanistic pathways, limitations in the data collected within cohorts may help explain the lack of significant association. The types of health conditions measured were not standardized across studies, limiting the number of conditions we could evaluate across multiple cohorts. Additionally, few studies among the COSMIC cohorts included inflammatory markers. It is possible that increased general inflammation with age, rather than the presence of specific diseases, contributes to slow gait (50,51). Future work is warranted and should incorporate both chronic health conditions and inflammatory biomarkers believed to influence gait such as interleukin-6 or C-reactive protein (49,52,53). This is especially warranted in developing countries, as most existing work reflects populations from high-income countries (54).

In contrast to previous studies (55,56), we found inconsistent evidence that smoking or drinking behaviors were significantly associated with gait speed. Although significance was not consistent across cohorts, the associations were in the expected direction such that abstinence from tobacco and/or any alcohol use was associated with faster gait. It is possible that our summary indicator of these behaviors was too imprecise to identify associations among these cohorts. For instance, alcohol consumption questions among the COSMIC cohorts spanned from how frequently one consumes alcohol in a typical week to whether the individual had ever consumed alcohol. Previous work suggests an inverted-U association between alcohol use and gait (57), which we were unable to model with our dichotomized measure. Future work should incorporate more sensitive measures of consumptive behaviors to explore potential dose-dependent associations with gait speed.

We also found a consistently nonsignificant association between APOE and gait speed across studies. Although contrary to our hypothesis, this partially replicates work that found e4 carrier status may not affect certain gait outcomes such as speed (58). APOE may exert a more complex influence on gait than we modeled in this study. For example, the association between APOE and cognitive function is not consistent across all populations and is moderated by factors such as Hispanic/Latino region of origin (59), physical activity engagement (60), or stress (61). APOE may exhibit a similarly complex association with gait speed such that their association depends on other sociodemographic or health characteristics. The potential interactive effect of APOE on gait outcomes warrants future research, as it may help explain inconsistent findings in the literature.

Limitations and Strengths

The COSMIC consortium offers a unique opportunity to examine gait and mobility among older adults across many ethnogeographic regions, but there are limitations to consider. Differences in gait speed among the cohorts may be attributed to differing gait speed protocols such as varying walk distances (62). Walkway distances ranged between 3 and 10 m, and half of the walkways were either 5 or 6 m; evidence suggests that walkways of this length may not meaningfully contribute to differences in gait speed (63). A related limitation was that not all studies assessed both types of gait speed, limiting our ability to understand how the pattern of associations within cohorts differs by usual versus rapid gait speed. Emerging evidence suggests that correlates of usual gait speed may differ from correlates of rapid gait speed (41,64–66). By including both usual and rapid gait speed assessments in future studies, we will gain novel insights into the unique and common correlates of different older adult gait parameters. Potential covariates were also not assessed in all cohort studies, thereby reducing the number of studies that were able to contribute to our analyses. This limitation may be due to the purpose of the original cohorts contributing to COSMIC, as these cohorts were primarily designed to examine correlates and predictors of cognitive decline and dementia rather than physical function. As data consortia such as COSMIC become more common, we recommend that future cohort studies identify a common set of measures to include in their assessment. This will allow for better harmonization across studies and can better inform context-specific versus universal correlates of physical function and mobility. A second limitation of this study was that gait speed and its correlates were not assessed in all cohorts. For example, all studies reported general health, but only 3 studies reported APOE carrier status. Third, correlates were not assessed with the same sensitivity across cohorts. For example, smoking and drinking behavior assessments ranged from weekly consumption in standardized units (eg, number of cigarettes per pack or ounces of alcohol) to a binary yes/no for lifetime engagement in these behaviors. Although the current study reports a positive association between gait speed and alcohol consumption, evidence suggests this is a nonlinear association such that light-to-moderate drinkers may outperform their abstinent and heavy-drinking peers (57). Future research with more sensitive measures of such behaviors is warranted before strong conclusions about the associations with gait speed among older adults are drawn. These results should also be interpreted with caution as they reflect cross-sectional differences rather than developmental changes. For example, longitudinal evidence implicates APOE polymorphism (67) and hypertension (47) as potential contributors to accelerated gait slowing, whereas other studies find similar rates of gait change across different clinically relevant subgroups (68).

Lastly, it is important to consider differences in recruitment and eligibility that may contribute to the reported ranges in gait speeds. Although all cohorts reflect “community-dwelling” older adults, the eligibility criteria for the cohorts were not consistent across studies. For instance, adults in the Tanzanian (IDEA study) cohort were eligible for participation even if they were unable to attend the on-site screening. Furthermore, institutionalized care for older adults in Tanzania is uncommon, so the functional abilities of older adults from this region may have more variability (ie, more adults with limited functional abilities but still community dwelling) than elsewhere (69).

Limitations notwithstanding, there are several strengths to this study. Heterogeneous definitions of “slow gait” can contribute to inconsistent prevalence estimates of slow gait across cohorts. One major strength of this study was the ability to quantify gait speed in meters per second rather than relying on clinically relevant cutpoints that may be inappropriate for these populations. As noted earlier, a substantial number of COSMIC participants would have been classified as slow walkers despite representing community-dwelling, ambulatory older adults with high subjective general health. By using meters per second rather than arbitrarily dichotomizing for slow gait, we are able to use this information to re-evaluate the appropriateness of using U.S.-derived normative values for other populations (70). A final notable strength of this study was the ability to examine these associations in full sample as well as sex-stratified analyses.

Implications and Future Directions

Gait speed is an easily tested, sensitive, and valid indicator of multisystemic older adult health and well-being. Although the correlates of gait speed are well characterized among certain populations, research has primarily relied on highly industrialized, Western countries and has not emphasized common correlates across different ethnogeographic regions. Understanding the consistency of gait speed correlates across different populations is important, as it can begin to inform whether the heterogeneity across populations is driven by context-specific correlations. For example, the consistent association between BMI and gait speed across cohorts may suggest that weight management-type interventions may be equally appropriate to implement across these ethnogeographic contexts. Notably, both nonmodifiable and modifiable correlates had a similar magnitude of association across cohorts. Despite the consistency among the intercorrelations with gait speed, the average gait speed among the cohorts was remarkably heterogeneous. This would suggest that current normative gait speed values, such as recommended speeds of 0.6–0.8 m/s to indicate clinically relevant slow gait (2,71), may be too fast for universal use, especially on self-paced (ie, usual) gait speed. Future research should identify whether such cutpoints are clinically relevant among other aging populations and whether the correlates of clinically impaired gait are similar across contexts. Together, this work will help our understanding of what is more universal versus cohort-specific correlates of gait among older adults worldwide.

Conclusion

This study is among the first to describe the average usual and rapid gait speeds across cohorts of older adults in Africa, as well as Asia and Australia. Gait speeds among these cohorts were similar to the speed of older adults among underrepresented countries in gait speed research (11). In particular, the gait speeds among the COSMIC cohorts were lower than that reported in U.S.-based cohort studies (72,73), especially among the African cohorts. Furthermore, the impact of clinical, psychological, and health behaviors on gait speed was remarkably consistent across cohorts.

Acknowledgments

We thank the participants and their informants for their time and generosity in contributing to this research. We also wish to acknowledge Drs. Shuzo Kumagai, Yu Nofuji, Takanori Honda, and the other contributors to the Sasaguri Genkimon Study (SGS). We also acknowledge the research teams for the 6 contributing cohort studies. The COSMIC Research Scientific Committee and additional principal investigators are listed at https://cheba.unsw.edu.au/consortia/cosmic/scientific-committee.

Funding

Funding for COSMIC comes from the National Institute on Aging of the National Institutes of Health under Award Number RF1AG05753. B.N.S. was also supported by a National Institute on Aging Kirschstein Institutional National Research Service Award (T32-AG055381) awarded to the University of Pittsburgh.

KLOSCAD was supported by the Korean Health Technology R&D Project grant from the Ministry for Health and & Welfare, Republic of Korea Grant # A092077 and the Korean Health Technology R&D Project through the Korean Health Industry Development Institute and Korea Dementia Research Center, funded by the Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea (HU20C0015). SGS was supported by the JSPS KAKENHI (Grant numbers JP17K09146 and 20H04030; PI: K.N.). Singapore Longitudinal Study of Aging-II (SLAS-II) was supported by research grants from the Agency for Science Technology and Research (A*STAR) Biomedical Research Council (Grant: 08/1/21/19/567) and from the National Medical Research Council (Grant: NMRC/1108/2007). The Sydney Memory and Ageing Study (Sydney MAS) has been funded by three National Health & Medical Research Council Program Grants (ID No. ID350833, ID568969, and APP1093083).

Conflict of Interest

None declared.

References

1.

Stone
 
ME
,
Lin
 
J
,
Dannefer
 
D
,
Kelley-Moore
 
JA
.
The continued eclipse of heterogeneity in gerontological research
.
J Gerontol B Psychol Sci Soc Sci
.
2017
;
72
(
1
):
162
167
. doi:10.1093/geronb/gbv068

2.

Abellan van Kan
 
G
,
Rolland
 
Y
,
Andrieu
 
S
, et al.
Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people: an International Academy on Nutrition and Aging (IANA) Task Force
.
J Nutr Health Aging
.
2009
;
13
(
10
):
881
889
. doi:10.1007/s12603-009-0246-z

3.

Soubra
 
R
,
Chkeir
 
A
,
Novella
 
J-L
.
A systematic review of thirty-one assessment tests to evaluate mobility in older adults
.
Biomed Res Int.
2019
;
2019
:
1354362
. doi:10.1155/2019/1354362

4.

Studenski
 
S
,
Perera
 
S
,
Patel
 
K
, et al.
Gait speed and survival in older adults
.
J Am Med Assoc
.
2011
;
305
(
1
):
50
58
. doi:10.1001/jama.2010.1923

5.

Guralnik
 
JM
,
Ferrucci
 
L
,
Pieper
 
CF
, et al.
Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the Short Physical Performance Battery
.
J Gerontol A Biol Sci Med Sci.
2000
;
55
(
4
):
M221
M231
. doi:10.1093/gerona/55.4.m221

6.

Evans
 
WJ
.
Functional outcomes for clinical trials in frail older persons: time to be moving
.
J Gerontol A Biol Sci Med Sci.
2008
;
63A
(
2
):
160
164
. doi:10.1093/gerona/63.2.160

7.

Henrich
 
J
,
Heine
 
SJ
,
Norenzayan
 
A
.
The weirdest people in the world
?
Behav Brain Sci.
2010
;
33
(
2-3
):
61
83; discussion 83
. doi:10.1017/S0140525X0999152X

8.

Peel
 
NM
,
Kuys
 
SS
,
Klein
 
K
.
Gait speed as a measure in geriatric assessment in clinical settings: a systematic review
.
J Gerontol A Biol Sci Med Sci.
2013
;
68
(
1
):
39
46
. doi:10.1093/gerona/gls174

9.

Graham
 
JE
,
Ostir
 
GV
,
Kuo
 
Y-F
,
Fisher
 
SR
,
Ottenbacher
 
KJ
.
Relationship between test methodology and mean velocity in timed walk tests: a review
.
Arch Phys Med Rehabil.
2008
;
89
(
5
):
865
872
. doi:10.1016/j.apmr.2007.11.029

10.

Graham
 
JE
,
Ostir
 
GV
,
Fisher
 
SR
,
Ottenbacher
 
KJ
.
Assessing walking speed in clinical research: a systematic review
.
J Eval Clin Pract.
2008
;
14
(
4
):
552
562
. doi:10.1111/j.1365-2753.2007.00917.x

11.

Capistrant
 
BD
,
Glymour
 
MM
,
Berkman
 
LF
.
Assessing mobility difficulties for cross-national comparisons: results from the World Health Organization Study on Global AGEing and adult health
.
J Am Geriatr Soc.
2014
;
62
(
2
):
329
335
. doi:10.1111/jgs.12633

12.

Thorpe
 
RJ
, Jr.,
Koster
 
A
,
Kritchevsky
 
SB
, et al.
Race, socioeconomic resources, and late-life mobility and decline: findings from the Health, Aging, and Body Composition Study
.
J Gerontol A Biol Sci Med Sci
.
2011
;
66A
(
10
):
111423
. doi:10.1093/gerona/glr102

13.

Blanco
 
I
,
Verghese
 
J
,
Lipton
 
RB
,
Putterman
 
C
,
Derby
 
CA
.
Racial differences in gait velocity in an urban elderly cohort
.
J Am Geriatr Soc.
2012
;
60
(
5
):
922
926
. doi:10.1111/j.1532-5415.2012.03927.x

14.

Kirkness
 
CS
,
Ren
 
J
.
Race differences: use of walking speed to identify community-dwelling women at risk for poor health outcomes—Osteoarthritis Initiative Study
.
Phys Ther.
2015
;
95
(
7
):
955
965
. doi:10.2522/ptj.20140028

15.

Ojagbemi
 
A
,
D’Este
 
C
,
Verdes
 
E
,
Chatterji
 
S
,
Gureje
 
O
.
Gait speed and cognitive decline over 2 years in the Ibadan Study of Aging
.
Gait & Posture
.
2015
;
41
(
2
):
736
740
. doi:10.1016/j.gaitpost.2015.01.011

16.

Boulifard
 
DA
,
Ayers
 
E
,
Verghese
 
J
.
Home based gait speed assessment: Normative data and racial/ethnic correlates among older adults
.
J Am Med Dir Assoc.
2019
;
20
(
10
):
1224
1229
. doi:10.1016/j.jamda.2019.06.002

17.

Rosso
 
AL
,
Studenski
 
SA
,
Chen
 
WG
, et al.
Aging, the central nervous system, and mobility
.
J Gerontol A Biol Sci Med Sci
.
2013
;
68
(
11
):
1379
1386
. doi:10.1093/gerona/glt089

18.

Franse
 
CB
,
Rietjens
 
JAC
,
Burdorf
 
A
, et al.
A prospective study on the variation in falling and fall risk among community-dwelling older citizens in 12 European countries
.
BMJ Open
.
2017
;
7
(
6
):
e015827
. doi:10.1136/bmjopen-2017-015827

19.

Higgins
 
JPT
,
Thomas
 
J
,
Chandler
 
J
,
Compston
 
M
,
Li
 
T
,
Page
 
MJ
, et al.
Cochrane Handbook for Systematic Reviews of Interventions
. 2nd ed.
Wiley
;
2019
.

20.

Heward
 
J
,
Stone
 
L
,
Paddick
 
S,-M
, et al.
A longitudinal study of cognitive decline in rural Tanzania: rates and potentially modifiable risk factors
.
Int Psychogeriatr.
2018
;
30
(
9
):
1333
1343
. doi:10.1017/S1041610217002861

21.

Gureje
 
O
,
Kola
 
L
,
Afolabi
 
E
.
Epidemiology of major depressive disorder in elderly Nigerians in the Ibadan Study of Ageing: a community-based survey
.
Lancet.
2007
;
390
(
9591
):
957
964
. doi:10.1016/s0140-6736(07)61446-9

22.

Kim
 
TH
,
Park
 
JH
,
Lee
 
JJ
, et al.
Overview of the Korean Longitudinal Study on Cognitive Aging and Dementia
.
Alzheimers Dement
.
2013
;
9
:
P626
P6P7
. doi:10.1016/j.jalz.2013.05.1268

23.

Narazaki
 
K
,
Nofuji
 
Y
,
Honda
 
T
,
Matsuo
 
E
,
Yonemoto
 
K
,
Kumagai
 
S
.
Normative data for the Montreal Cognitive Assessment in a Japanese community-dwelling older population
.
Neuroepidemiology.
2013
;
40
(
1
):
23
29
. doi:10.1159/000339753

24.

Feng
 
L
,
Chong
 
MS
,
Lim
 
WS
, et al.
Metabolic syndrome and amnestic mild cognitive impairment: Singapore Longitudinal Ageing Study-2 findings
.
J Alzheimers Dis
.
2013
;
34
(
3
):
649
657
. doi:10.3233/jad-121885

25.

Sachdev
 
PS
,
Brodaty
 
H
,
Reppermund
 
S
, et al.
The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70–90 years
.
Int Psychogeriatr.
2010
;
22
(
8
):
1248
1264
. doi:10.1017/S1041610210001067

26.

Melzer
 
D
,
Dik
 
MG
,
van Kamp
 
GJ
,
Jonker
 
C
,
Deeg
 
DJ
.
The apolipoprotein E e4 polymorphism is strongly associated with poor mobility performance test results but not self-reported limitation in older people
.
J Gerontol A Biol Sci Med Sci.
2005
;
60
(
10
):
1319
1323
. doi:10.1093/gerona/60.10.1319

27.

Folstein
 
MF
,
Folstein
 
SE
,
McHugh
 
PR
.
“Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician
.
J Psychiatr Res.
1975
;
12
(
3
):
189
198
. doi:10.1016/0022-3956(75)90026-6

28.

Bush
 
SS
.
Neurosensory center comprehensive examination for aphasia
. In:
Kreutzer
 
JS
,
DeLuca
 
J
,
Caplan
 
B
, eds.
Encyclopedia of Clinical Neuropsychology
.
Springer New York
;
2011
:
1772
1773
.

29.

Reitan
 
RM
.
Validity of the Trail Making Test as an indicator of organic brain damage
.
Percept Mot Skills.
1958
;
8
(
3
):
271
276
. doi:10.2466/pms.8.7.271-276

30.

Yesavage
 
JA
,
Brink
 
TL
,
Rose
 
TL
, et al.
Development and validation of a geriatric depression screening scale: a preliminary report
.
J Psychiatr Res.
1982
;
17
(
1
):
37
49
. doi:10.1016/0022-3956(82)90033-4

31.

Dwyer-Lindgren
 
L
,
Mackenbach
 
JP
,
van Lenthe
 
FJ
,
Mokdad
 
AH
.
Self-reported general health, physical distress, mental distress, and activity limitation by US county, 1995–2012
Popul Health Metr
.
2017
;
15
:
16
. doi:10.1186/s12963-017-0133-5

32.

Roush
 
J
,
Bay
 
RC
.
Percentile ranks for walking speed in subjects 70–79 years: a meta-analysis
.
Internet J Allied Health Sci Pract
.
2014
;
12
(
1
):
1
11
. doi:10.46743/1540-580x/2014.1468

33.

Bohannon
 
RW
,
Wang
 
Y-C
.
Four-meter gait speed: normative values and reliability determined for adults participating in the NIH Toolbox Study
.
Arch Phys Med Rehabil.
2019
;
100
(
3
):
509
513
. doi:10.1016/j.apmr.2018.06.031

34.

Middleton
 
A
,
Fritz
 
SL
,
Lusardi
 
M
.
Walking speed: the functional vital sign
.
J Aging Phys Act.
2015
;
23
(
2
):
314
322
. doi:10.1123/japa.2013-0236

35.

Payne
 
CF
,
Gómez-Olivé
 
FX
,
Kahn
 
K
,
Berkman
 
L
.
Physical function in an aging population in rural South Africa: findings from HAALSI and cross-national comparisons with HRS sister studies
.
J Gerontol B Psychol Sci Soc Sci
.
2017
;
72
(
4
):
665
679
. doi:10.1093/geronb/gbx030

36.

de Almeida Busch
 
T
,
Duarte
 
YA
,
Pires Nunes
 
D
, et al.
Factors associated with lower gait speed among the elderly living in a developing country: a cross-sectional population-based study
.
BMC Geriatr.
2015
;
15
:
35
. doi:10.1186/s12877-015-0031-2

37.

German
 
A
,
Mesch
 
G
,
Hochberg
 
Z
.
People are taller in countries with better environmental conditions
.
Front Endocrinol.
2020
;
11
:
106
. doi:10.3389/fendo.2020.00106

38.

Elbaz
 
A
,
Artaud
 
F
,
Dugravot
 
A
,
Tzourio
 
C
,
Singh-Manoux
 
A
.
The gait speed advantage of taller stature is lost with age
.
Sci Rep.
2018
;
8
:
1485
. doi:10.1038/s41598-018-19882-1

39.

Guthold
 
R
,
Stevens
 
GA
,
Riley
 
LM
,
Bull
 
FC
.
Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1.9 million participants
.
Lancet Glob Health
.
2018
;
6
(
10
):
e1077
e1086
. doi:10.1016/S2214-109X(18)30357-7

40.

Azmi
 
DI
,
Karim
 
HA
,
Amin
 
MZM
.
Comparing the walking behaviour between urban and rural residents
.
Procedia Soc Behav Sci
.
2012
;
68
:
406
416
. doi:10.1016/j.sbspro.2012.12.237

41.

Mantel
 
A
,
Trapuzzano
 
A
,
Chizmar
 
S
,
Haffke
 
L
,
Dawson
 
N
.
An investigation of the predictors of comfortable and fast gait speed in community-dwelling older adults
.
J Geriatr Phys Therapy
.
2019
;
42
(
4
):
E62
E68
. doi:10.1519/jpt.0000000000000216

42.

Sialino
 
LD
,
Schaap
 
LA
,
van Oostrom
 
SH
, et al.
The sex difference in gait speed among older adults: how do sociodemographic, lifestyle, social, and health determinants contribute
?
BMC Geriatr.
2021
;
21
:
340
. doi:10.1186/s12877-021-02279-7

43.

Yao
 
S-S
,
Meng
 
X
,
Cao
 
G-Y
, et al.
Associations between multimorbidity and physical performance in older Chinese adults
.
Int J Environ Res Public Health.
2020
;
17
(
12
):
45464546
. doi:10.3390/ijerph17124546

44.

Ortiz
 
PJ
,
Tello
 
T
,
Aliaga
 
AG
, et al.
Effect of multimorbidity on gait speed in well-functioning older people: a population-based study in Peru
.
Geriatr Gerontol Int
.
2018
;
18
(
2
):
293
300
. doi:10.1111/ggi.13182

45.

Vive
 
S
,
Elam
 
C
,
Bunketorp-Käll
 
L
.
Comfortable and maximum gait speed in individuals with chronic stroke and community-dwelling controls
.
J Stroke Cerebrovasc Dis.
2021
;
30
(
10
):
106023106023
. doi:10.1016/j.jstrokecerebrovasdis.2021.106023

46.

Weidung
 
B
,
Boström
 
G
,
Toots
 
A
, et al.
Blood pressure, gait speed, and mortality in very old individuals: a population-based cohort study
.
J Am Med Dir Assoc.
2015
;
16
(
3
):
208204
208214
. doi:10.1016/j.jamda.2014.09.004

47.

Rosano
 
C
,
Longstreth
WT
, Jr.
,
Boudreau
 
R
, et al.
High blood pressure accelerates gait slowing in well-functioning older adults over 18-years of follow-up
.
J Am Geriatr Soc.
2011
;
59
(
3
):
390
397
. doi:10.1111/j.1532-5415.2010.03282.x

48.

Ferrucci
 
L
,
Fabbri
 
E
.
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
.
Natl Rev Cardiol
.
2018
;
15
(
9
):
505
522
. doi:10.1038/s41569-018-0064-2

49.

Verghese
 
J
,
Holtzer
 
R
,
Oh-Park
 
M
,
Derby
 
CA
,
Lipton
 
RB
,
Wang
 
C
.
Inflammatory markers and gait speed decline in older adults
.
J Gerontol A Biol Sci Med Sci.
2011
;
66
(
10
):
1083
1089
. doi:10.1093/gerona/glr099

50.

Windham
 
BG
,
Wilkening
 
SR
,
Lirette
 
ST
, et al.
Associations between inflammation and physical function in African Americans and European Americans with prevalent cardiovascular risk factors
.
J Am Geriatr Soc.
2016
;
64
(
7
):
1448
1455
. doi:10.1111/jgs.14229

51.

Fabbri
 
E
,
An
 
Y
,
Zoli
 
M
, et al.
Aging and the burden of multimorbidity: associations with inflammatory and anabolic hormonal biomarkers
.
J Gerontol A Biol Sci Med Sci.
2015
;
70
(
1
):
63
70
. doi:10.1093/gerona/glu127

52.

Kositsawat
 
J
,
Barry
 
LC
,
Kuchel
 
GA
.
C-reactive protein, vitamin D deficiency, and slow gait speed
.
J Am Geriatr Soc.
2013
;
61
(
9
):
1574
1579
. doi:10.1111/jgs.12403

53.

Nadkarni
 
NK
,
Boudreau
 
RM
,
Studenski
 
SA
, et al.
Slow gait, white matter characteristics, and prior 10-year interleukin-6 levels in older adults
Neurology
.
2016
;
87
(
19
):
1993
1999
. doi:10.1212/WNL.0000000000003304

54.

Ryan
 
A
,
Wallace
 
E
,
O’Hara
 
P
,
Smith
 
SM
.
Multimorbidity and functional decline in community-dwelling adults: a systematic review
.
Health Qual Life Outcomes
.
2015
;
13
:
168
. doi:10.1186/s12955-015-0355-9

55.

Verlinden
 
VJA
,
Maksimovic
 
A
,
Mirza
 
SS
, et al.
The associations of alcohol, coffee and tobacco consumption with gait in a community-dwelling population
.
Eur J Clin Nutr.
2016
;
70
:
116
122
. doi:10.1038/ejcn.2015.120

56.

Sainio
 
P
,
Martelin
 
T
,
Koskinen
 
S
,
Heliövaara
 
M
.
Educational differences in mobility: the contribution of physical workload, obesity, smoking and chronic conditions
.
J Epidemiol Commun Health
.
2007
;
61
(
5
):
401
408
. doi:10.1136/jech.2006.048306

57.

Seematter-Bagnoud
 
L
,
Büla
 
C
,
Santos-Eggimann
 
B
.
The association between different levels of alcohol use and gait under single and dual task in community-dwelling older persons aged 65 to 70 years
.
Curr Gerontol Geriatr Res
.
2016
;
2016
:
2018507
. doi:10.1155/2016/2018507

58.

Ben-Avraham
 
D
,
Karasik
 
D
,
Verghese
 
J
, et al.
The complex genetics of gait speed: genome-wide meta-analysis approach
.
Aging (Milano).
2017
;
9
(
1
):
209
246
. doi:10.18632/aging.101151

59.

Granot-Hershkovitz
 
E
,
Tarraf
 
W
,
Kurniansyah
 
N
, et al.
APOE alleles’ association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos-investigation of neurocognitive aging (HCHS/SOL)
Alzheimers Dement
.
2021
;
17
(
3
):
466
474
. doi:10.1002/alz.12205

60.

Stringa
 
N
,
van Schoor
 
NM
,
Milaneschi
 
Y
, et al.
Physical activity as moderator of the association between APOE and cognitive decline in older adults: results from three longitudinal cohort studies
.
J Gerontol A Biol Sci Med Sci.
2020
;
75
(
10
):
1880
1886
. doi:10.1093/gerona/glaa054

61.

Peavy
 
GM
,
Lange
 
KL
,
Salmon
 
DP
, et al.
The effects of prolonged stress and APOE genotype on memory and cortisol in older adults
.
Biol Psychiatry.
2007
;
62
(
5
):
472
478
. doi:10.1016/j.biopsych.2007.03.013

62.

Stuck
 
AK
,
Bachman
 
M
,
Füllemann
 
P
,
Josephson
 
KR
,
Stuck
 
AE
.
Effect of testing procedures on gait speed measurement: a systematic review
.
PLoS One.
2020
;
15
(
6
):
e0234200
. doi:10.1371/journal.pone.0234200

63.

Ng
 
SSM
,
Ng
 
PCM
,
Lee
 
CYW
, et al.
Assessing the walking speed of older adults: the influence of walkway length
.
Am J Phys Med Rehab
.
2013
;
92
(
9
):
776
780
. doi:10.1097/PHM.0b013e31828769d0

64.

Davis
 
JRC
,
Knight
 
SP
,
Donoghue
 
OA
, et al.
Comparison of gait speed reserve, usual gait speed, and maximum gait speed of adults aged 50+ in Ireland using explainable machine learning
.
Front Netw Physiol
.
2021
;
1
:
754477
. doi:10.3389/fnetp.2021.754477

65.

Ruggero
 
CR
,
Bilton
 
TL
,
Teixeira
 
LF
, et al.
Gait speed correlates in a multiracial population of community-dwelling older adults living in Brazil: a cross-sectional population-based study
.
BMC Public Health
.
2013
;
13
:
182
. doi:10.1186/1471-2458-13-182

66.

Peller
 
A
,
Suarez
 
L
,
Trauzzano
 
A
,
Stock
 
MS
,
Dawson
 
N
.
Cognitive and physical indicators of gait speed in the community-dwelling older adult
.
OBM Geriatrics
.
2022
;
6
(
1
). doi:10.21926/obm.geriatr.2201188

67.

Buchman
 
AS
,
Boyle
 
PA
,
Wilson
 
RS
,
Beck
 
TL
,
Kelly
 
JF
,
Bennett
 
DA
.
Apolipoprotein E e4 allele is associated with more rapid motor decline in older person. Alzheimer Dis Assoc Disord
.
2009
;23:63–69. doi: 10.1097/wad.0b013e31818877b5

68.

Perera
 
S
,
Studenski
 
S
,
Newman
 
A
, et al.
Are estimates of meaningful decline in mobility performance consistent among clinically important subgroups? (Health ABC Study)
.
J Gerontol A Biol Sci Med Sci.
2014
;
69
(
10
):
1260
1268
. doi:10.1093/gerona/glu033

69.

Isangula
 
KG
.
The dangers of being old in rural Tanzania: a call for interventions for strengthening palliative care in low-income communities
.
Front Aging
.
2022
;
3
:
888396
. doi:10.3389/fragi.2022.888396

70.

Figgins
 
E
,
Pieruccini-Faria
 
F
,
Speechley
 
M
,
Montero-Odasso
 
M
.
Potentially modifiable risk factors for slow gait in community-dwelling older adults: a systematic review
.
Ageing Res Rev.
2021
;
66
:
101253
. doi:10.1016/j.arr.2020.101253

71.

Abellan van Kan
 
G
,
Rolland
 
Y
,
Bergman
 
H
,
Morley
 
J
,
Kritchevsky
 
JB
,
Vellas
 
B
.
The I.A.N.A Task Force on frailty assessment of older people in clinical practice
.
J Nutr Health Aging
.
2008
;
12
(
1
):
29
37
. doi:10.1007/bf02982161

72.

Bohannon
 
RW
.
Comfortable and maximum walking speed of adults aged 20–79 years: reference values and determinants
.
Age Ageing.
1997
;
26
:
15
19
. doi:10.1093/ageing/26.1.15

73.

Bohannon
 
RW
.
Population representative gait speed and its determinants
.
J Geriatr Phys Therapy
.
2008
;
31
(
2
):
49
52
. doi:10.1519/00139143-200831020-00002

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights)
Decision Editor: Lewis A Lipsitz, MD, FGSA
Lewis A Lipsitz, MD, FGSA
Decision Editor
Search for other works by this author on: